Booth CM - Search Results

1

Contact Days Associated With Cancer Treatments in the CCTG LY.12 Trial.

Gupta A, Hay AE, Crump M, Djurfeldt MS, Zhu L, Cheung MC, Shepherd LE, Chen BE, Booth CM. Gupta A, et al. Among authors: booth cm. Oncologist. 2023 Sep 7;28(9):799-803. doi: 10.1093/oncolo/oyad128. Oncologist. 2023. PMID: 37226534 Free PMC article. Clinical Trial.

2

Randomised controlled trials in oncology closed early for benefit: trends in methodology, results, and interpretation.

Booth CM, Ohorodnyk P, Zhu L, Tu D, Meyer RM. Booth CM, et al. Eur J Cancer. 2011 Apr;47(6):854-63. doi: 10.1016/j.ejca.2010.12.005. Epub 2011 Feb 4. Eur J Cancer. 2011. PMID: 21296570 Review.

3

Alignment of practice guidelines with targeted-therapy drug funding policies in Ontario.

Ramjeesingh R, Meyer RM, Brouwers M, Chen BE, Booth CM. Ramjeesingh R, et al. Among authors: booth cm. Curr Oncol. 2013 Feb;20(1):e21-33. doi: 10.3747/co.20.1166. Curr Oncol. 2013. PMID: 23444033 Free PMC article.

4

Temsirolimus Maintenance Therapy After Docetaxel Induction in Castration-Resistant Prostate Cancer.

Emmenegger U, Booth CM, Berry S, Sridhar SS, Winquist E, Bandali N, Chow A, Lee C, Xu P, Man S, Kerbel RS, Ko YJ. Emmenegger U, et al. Among authors: booth cm. Oncologist. 2015 Dec;20(12):1351-2. doi: 10.1634/theoncologist.2015-0220. Epub 2015 Nov 5. Oncologist. 2015. PMID: 26542984 Free PMC article. Clinical Trial.

5

Prognostic and predictive effects of diabetes, hypertension, and coronary artery disease among women on extended adjuvant letrozole: NCIC CTG MA.17.

Goodwin RA, Jamal R, Booth CM, Goss PE, Eisenhauer EA, Tu D, Shepherd LE. Goodwin RA, et al. Among authors: booth cm. Eur J Cancer. 2016 May;58:97-103. doi: 10.1016/j.ejca.2016.01.014. Epub 2016 Mar 14. Eur J Cancer. 2016. PMID: 26986765

6

Apixaban to Prevent Venous Thromboembolism in Patients with Cancer.

Carrier M, Abou-Nassar K, Mallick R, Tagalakis V, Shivakumar S, Schattner A, Kuruvilla P, Hill D, Spadafora S, Marquis K, Trinkaus M, Tomiak A, Lee AYY, Gross PL, Lazo-Langner A, El-Maraghi R, Goss G, Le Gal G, Stewart D, Ramsay T, Rodger M, Witham D, Wells PS; AVERT Investigators. Carrier M, et al. N Engl J Med. 2019 Feb 21;380(8):711-719. doi: 10.1056/NEJMoa1814468. Epub 2018 Dec 4. N Engl J Med. 2019. PMID: 30511879 Clinical Trial.

7

Reliability of Oncology Value Framework Outputs: Concordance Between Independent Research Groups.

Del Paggio JC, Cheng S, Booth CM, Cheung MC, Chan KKW. Del Paggio JC, et al. Among authors: booth cm. JNCI Cancer Spectr. 2018 Dec 13;2(3):pky050. doi: 10.1093/jncics/pky050. eCollection 2018 Jul. JNCI Cancer Spectr. 2018. PMID: 31360865 Free PMC article.

8

Application of Value Frameworks to the Design of Clinical Trials: The Canadian Cancer Trials Group Experience.

Del Paggio JC, Fundytus AM, Hopman WM, Pater JL, Chen BE, Brundage MD, Hay AE, Booth CM. Del Paggio JC, et al. Among authors: booth cm. J Natl Cancer Inst. 2021 Oct 1;113(10):1422-1428. doi: 10.1093/jnci/djab051. J Natl Cancer Inst. 2021. PMID: 33760057

9

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials.

Sharma S, Wells JC, Hopman WM, Del Paggio JC, Gyawali B, Hammad N, Hay AE, Booth CM. Sharma S, et al. Among authors: booth cm. Curr Oncol. 2021 Apr 13;28(2):1518-1527. doi: 10.3390/curroncol28020143. Curr Oncol. 2021. PMID: 33924380 Free PMC article.

10

The Time Toxicity of Cancer Treatment.

Gupta A, Eisenhauer EA, Booth CM. Gupta A, et al. Among authors: booth cm. J Clin Oncol. 2022 May 20;40(15):1611-1615. doi: 10.1200/JCO.21.02810. Epub 2022 Mar 2. J Clin Oncol. 2022. PMID: 35235366 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

399 results

Search Page